Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Jun 14;3(4):1010–1024. doi: 10.1002/cam4.269

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2014 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Patient distribution at initial diagnosis and at recurrence. (A) Among the newly diagnosed IVL patients, 308 (41%) presented in the CNS, 145 (20%) in skin, 124 (17%) in BM and spleen, 50 (7%) in lungs, 101 (13%) in other sites and 12 (2%) unknown. Among the 250 patients diagnosed at postmortem, IVL affecting the CNS was highest compared to other organ sites: 151 (60%) CNS, 21 (8%) skin, 28 (11%) BM and spleen, and 17 (7%) lung and 33 (13%) other organs. (B) Same-organ recurrence was highest in 14 of 16 (88%) CNS, as compared to 5 of 22 (23%) skin, 5 of 10 (50%) BM and spleen, and 1 of 5 (20%) lung IVL's. BM, bone marrow; CNS, central nervous system; IVL, intravascular lymphomatosis.